BRCA1 and breast cancer: Additionally, delivery of EF2K-specific siRNAs into BRCA1-mutated breast cancer in an orthotopic xenograft model by silica-coated cobalt-ferrite nanoparticles considerably diminishes tumor growth and metastasis [22].